Research

Hormonal

Increased adiposity (BMI) within the normal to overweight range (non-obese) causally alters the systemic metabolite profile, adversely affecting cardiometabolic risk markers including lipoprotein subclasses, amino acids, and inflammatory markers.

If you are in your 20s or 30s and your BMI is in the overweight range (even if not obese), your body's metabolic chemistry is likely already shifting in ways that increase long-term health risks. This isn't just about weight; it's about how your body processes fats and sugars. Maintaining a healthy weight now can prevent these metabolic shifts from becoming entrenched.

StrongSupportsVERY_HIGH confidence
Mendelian randomization indicates causal adverse effects of increased adiposity with multiple cardiometabolic risk markers across the metabolite profile in adolescents and young adults within the non-obese weight range.
Peter Würtz et al. · PLoS Medicine · 2014

Why this rating

Large sample size (n=12,664), Mendelian randomization design to establish causality, and replication across multiple cohorts.

Source

Metabolic Signatures of Adiposity in Young Adults: Mendelian Randomization Analysis and Effects of Weight Change

Peter Würtz et al. · PLoS Medicine · 2014

DOI 10.1371/journal.pmed.1001765

cohort · n=12664Cited 306×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →